INTS3
Basic information
Region (hg38): 1:153728050-153774808
Previous symbols: [ "C1orf60" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the INTS3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 16 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 16 | 0 | 0 |
Variants in INTS3
This is a list of pathogenic ClinVar variants found in the INTS3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-153728654-A-G | not specified | Uncertain significance (Oct 05, 2021) | ||
1-153728678-C-T | not specified | Uncertain significance (Feb 02, 2022) | ||
1-153728690-C-T | not specified | Uncertain significance (Aug 02, 2023) | ||
1-153728773-G-A | not specified | Uncertain significance (Aug 22, 2023) | ||
1-153740682-C-T | not specified | Uncertain significance (Jul 17, 2024) | ||
1-153741336-C-G | not specified | Uncertain significance (Oct 05, 2021) | ||
1-153746985-G-A | not specified | Uncertain significance (Jul 12, 2023) | ||
1-153748713-T-C | not specified | Uncertain significance (Sep 08, 2024) | ||
1-153751099-T-C | not specified | Uncertain significance (May 06, 2024) | ||
1-153751198-C-A | not specified | Uncertain significance (Jan 29, 2024) | ||
1-153752375-C-T | not specified | Uncertain significance (May 30, 2024) | ||
1-153757762-C-T | not specified | Uncertain significance (Jul 09, 2021) | ||
1-153760389-G-A | not specified | Uncertain significance (Aug 12, 2021) | ||
1-153760837-A-G | not specified | Uncertain significance (May 11, 2022) | ||
1-153760867-G-A | not specified | Uncertain significance (Jan 08, 2024) | ||
1-153761623-T-C | not specified | Uncertain significance (Oct 29, 2024) | ||
1-153762839-A-G | not specified | Uncertain significance (Sep 20, 2024) | ||
1-153763296-T-C | Malignant tumor of prostate | Uncertain significance (-) | ||
1-153763837-C-T | not specified | Uncertain significance (Oct 20, 2023) | ||
1-153768899-G-A | not specified | Uncertain significance (May 26, 2022) | ||
1-153770211-C-G | not specified | Uncertain significance (Mar 04, 2024) | ||
1-153771892-T-A | not specified | Uncertain significance (Dec 05, 2024) | ||
1-153771942-G-C | not specified | Uncertain significance (Dec 10, 2024) | ||
1-153772398-T-G | Myoepithelial tumor | Uncertain significance (Nov 01, 2022) | ||
1-153772696-A-G | not specified | Uncertain significance (Apr 12, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
INTS3 | protein_coding | protein_coding | ENST00000318967 | 30 | 46013 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000283 | 125726 | 0 | 22 | 125748 | 0.0000875 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 4.41 | 293 | 596 | 0.491 | 0.0000340 | 6860 |
Missense in Polyphen | 67 | 210.54 | 0.31824 | 2389 | ||
Synonymous | 1.07 | 213 | 234 | 0.911 | 0.0000134 | 2000 |
Loss of Function | 6.48 | 10 | 67.5 | 0.148 | 0.00000379 | 713 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000868 | 0.0000868 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000123 | 0.000123 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the Integrator (INT) complex. The Integrator complex is involved in the small nuclear RNAs (snRNA) U1 and U2 transcription and in their 3'-box-dependent processing. The Integrator complex is associated with the C-terminal domain (CTD) of RNA polymerase II largest subunit (POLR2A) and is recruited to the U1 and U2 snRNAs genes (Probable). Mediates recruitment of cytoplasmic dynein to the nuclear envelope, probably as component of the INT complex (PubMed:23904267). {ECO:0000269|PubMed:23904267, ECO:0000305|PubMed:16239144}.;
- Pathway
- Gene expression (Transcription);RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription
(Consensus)
Recessive Scores
- pRec
- 0.136
Intolerance Scores
- loftool
- 0.175
- rvis_EVS
- -1.29
- rvis_percentile_EVS
- 5.03
Haploinsufficiency Scores
- pHI
- 0.517
- hipred
- Y
- hipred_score
- 0.736
- ghis
- 0.555
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.936
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ints3
- Phenotype
Gene ontology
- Biological process
- DNA repair;cellular response to DNA damage stimulus;mitotic cell cycle checkpoint;response to ionizing radiation;snRNA processing;snRNA transcription by RNA polymerase II
- Cellular component
- nucleus;nucleoplasm;nucleolus;cytoplasm;integrator complex;SOSS complex
- Molecular function
- protein binding